Injectable porous microsphere scaffold as well as preparation method and application thereof
Through the combination of the remulsant-solvent volatilization method and the porogenic agent of carboxymethylcellulose, a porous microsphere stent with high pore ratio and narrow pore size distribution was prepared, which solved the problems of unstable performance and safety hazards in the prior art. It realizes efficient cell carriers and medical beauty filling materials.
Patent Information
- Application Number
- CN202310662426.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-06
- Publication Date
- 2024-12-06
AI Technical Summary
The existing injectable porous microsphere stent materials are difficult to control in porosity and pore size distribution, resulting in unstable performance, poor injection performance, and biocompatibility and safety risks, which cannot meet clinical needs.
By adjusting the emulsification shear rate, aqueous phase and oil phase ratio, using sodium carboxymethylcellulose as pore-generating agent, forming an O/W/W composite emulsion, removing the organic solvent under reduced pressure, and freezing Drying prepared porous microsphere scaffolds with high porosity and narrow pore size distribution.
A porous microsphere scaffold with uniform particle size, regular appearance, high porosity and narrow pore distribution is achieved. It has excellent carrier performance and cell growth environment, and the material biocompatibility and safety are improved, which is suitable for tissue engineering and medical beauty applications. .
Smart Images

Figure CN119075014A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of preparation of scaffold materials, and in particular relates to an injectable porous microsphere scaffold and a preparation method and application thereof. Background Art
[0002] Tissue engineering is an interdisciplinary subject that studies the structure, function and growth mechanism of biological tissues through materials engineering and life sciences, in order to develop biological substitutes that can repair, maintain or improve the function of damaged tissues. Tissue engineering scaffolds are an important means of repairing and regenerating damaged tissues in medicine.
[0003] There are many types of tissue engineering scaffolds, but the most widely used are solid tissue engineering scaffolds. According to the way the scaffolds are implanted in the body, solid tissue engineering scaffolds can be mainly divided into two categories: one is an injectable scaffold with microspheres as the main body. This type of injectable scaffold has both good fluidity and certain mechanical strength. It mainly includes the following two types: (1) porous microspheres, which can increase the specific surface area of the microspheres to facilitate cell attachment and provide a spatial void structure for cell proliferation and differentiation in the body, but it is difficult to control the release of growth factors or chemical drugs; (2) polymer microspheres loaded with growth factors or chemical drugs, but without porous structures or with less porous structures, which is not conducive to cell adhesion on the scaffold and cannot provide enough space for cell growth. The other type is non-injectable scaffolds implanted by surgery. Non-injectable scaffolds have better mechanical properties and structural diversity, but they need to be implanted by surgery, which often causes greater trauma to patients. They are mostly in the form of films, sheets, blocks, etc.
[0004] Commonly used polymers in tissue engineering scaffold materials include polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA). However, the degradation products of PLGA itself are acidic, which may inactivate the drugs carried and may also cause immune rejection in the body; and PCL has the disadvantages of strong crystallinity and slow degradation rate in the body, which limits the application scope of these materials in the biomedical field. In the current literature, the porosity and pore size of the prepared PCL porous microspheres are low, and the injectability is poor, which cannot meet the ideal scaffold requirements.
[0005] Polylactic acid and its copolymers are widely used in absorbable medical devices, tissue engineering, drug sustained release, and medical cosmetology due to their good biocompatibility and biodegradability. The degradation product of polylactic acid in the body is L-lactic acid, which is an intermediate product of the tricarboxylic acid cycle during sugar metabolism in the human body. Its final metabolites, carbon dioxide and water, can be smoothly excreted from the body. Injectable polylactic acid (PLLA) microspheres can be used as beauty products. After subcutaneous injection, they have the effect of beauty and wrinkle removal. However, there are few reports on porous PLLA microsphere tissue engineering scaffolds on the market. This is because the existing injectable PLLA microspheres do not have a porous structure, and the porosity is uncontrollable during the processing process, resulting in the material being not very effective as a tissue engineering scaffold.
[0006] Patent CN109010910A discloses a method for preparing injectable L-polylactic acid microspheres, which comprises adding an organic solution of L-polylactic acid to an aqueous solution of sodium carboxymethylcellulose / mannitol, removing the organic solvent in the mixed solution, and freeze-drying to obtain injectable L-polylactic acid microspheres. Unfortunately, however, the microspheres are solid microspheres and do not have a porous structure. When used as tissue engineering scaffolds, they are not conducive to the loading and production of cells on the microspheres, and do not have drug loading capacity.
[0007] Patent CN111298196A discloses a method for preparing porous polylactic acid microspheres, wherein polyethylene glycol is used as a porogen to prepare an O / W emulsion, and after the solvent evaporates, the solution is freeze-dried to obtain a porous polylactic acid microsphere product. Although the patented method prepares porous polylactic acid microspheres, the polylactic acid microspheres obtained by the method have poor hydrophilicity, low porosity, and difficult to control pore size range, which is not conducive to dispersion in the human body's water environment and is easy to aggregate into blocks after being injected into the human body.
[0008] Patent CN111249524A discloses a high-porosity polycaprolactone porous microsphere scaffold for bone tissue regeneration and its preparation method, which uses gelatin as a porogen and is based on the double emulsion-solvent evaporation method to prepare polycaprolactone porous microspheres. The surface and internal pores of the polycaprolactone porous microspheres are interconnected, the porosity of the microspheres is 75.28-90.73%, and the pore size is 43-217μm. It can be seen that the process method has a large difference in the porosity of the porous microsphere scaffold, a large difference in the pore size, and the performance of the prepared porous microsphere scaffold is unstable. In addition, the porogen used is animal-derived gelatin, which has certain potential risks in biocompatibility and medical device safety.
[0009] In summary, the existing injectable porous microspheres cannot be used well as scaffolds. The main reasons are: either the existing microsphere scaffold materials cannot be loaded with growth factors because they do not have a pore structure suitable for cell growth; or the porosity of the prepared microspheres is low, and the pore size range is difficult to accurately control. The performance stability of this type of scaffold production is poor and cannot meet the clinical demand for an ideal scaffold; or the morphology of the prepared porous microsphere scaffold material is not uniform enough, it is not a regular sphere, and the injection performance is poor, posing a safety hazard.
[0010] Therefore, how to provide an injectable porous microsphere scaffold with controllable production process, high porosity, small pore size range, high performance stability, uniform morphology, regular shape, good injection performance and high safety has become a technical problem that needs to be solved urgently. Summary of the invention
[0011] The present invention is to solve the above technical problems, thereby providing an injectable porous microsphere scaffold and its preparation method and application. The technical purpose of the present invention is to provide an injectable porous microsphere scaffold and its preparation method with controllable production process, high porosity, small pore size range, high performance stability, uniform morphology, regular shape, good injection performance, and high safety, so as to solve the problems that the existing methods cannot achieve continuous industrial production of injectable porous microsphere scaffolds, product quality cannot be guaranteed, and the porosity and pore size range and performance stability are poor.
[0012] In order to achieve the above object, the technical solution adopted by the present invention is as follows:
[0013] The present invention first provides a method for preparing an injectable porous microsphere scaffold, comprising the following steps:
[0014] (1) dissolving L-polylactic acid in an organic solvent to obtain an oil phase;
[0015] (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase;
[0016] (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification shearing;
[0017] (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing to obtain a W / O / W composite emulsion;
[0018] (5) stirring under reduced pressure to remove the organic solvent to obtain solidified composite microspheres; collecting the microspheres, washing them, and freeze-drying them to obtain the injectable porous microsphere scaffold.
[0019] The preparation method provided by the present invention can obtain a porous microsphere scaffold with good product performance, uniform particle size, spherical appearance, high porosity, narrow pore size distribution, high injectability and good stability. The method of the present invention has the following advantages:
[0020] 1. The preparation method of the present invention adopts the double emulsion-solvent evaporation method, and the parameters such as the emulsification shear rate, the ratio of the water phase to the oil phase, etc. can be adjusted to control the particle size and porosity of the microspheres, thereby obtaining high-porosity porous microspheres, and the voids of the microspheres are interconnected, which is beneficial to the growth of cells and tissues, the transmission of oxygen and nutrients, and the discharge of metabolic products.
[0021] 2. The porous microspheres prepared by the present invention have a larger specific surface area than solid microspheres, and are a better carrier. In addition, the shape of the microspheres is more uniform and the sphericity is good.
[0022] 3. The present invention uses sodium carboxymethyl cellulose as a porogen, which can replace the role of gelatin and also stabilize the solution system. In addition, since sodium carboxymethyl cellulose is a plant-derived material, it overcomes the potential disadvantages of using animal-derived gelatin as a porogen in terms of biocompatibility and medical device safety.
[0023] 4. The PLLA material selected in the present invention has better biocompatibility than other polymer materials such as PCL, PLGA, etc., and the final products of its degradation in the body are carbon dioxide and water.
[0024] 5. Carboxymethyl cellulose has a wide molecular weight distribution. The pore size can be controlled by using different molecular weights and concentrations. In addition, controlling the particle size can give it excellent injection performance.
[0025] 6. It has a wide range of uses. In addition to being used as a scaffold material to facilitate cell proliferation and drug loading, beneficial factors can also be embedded in the porous structure for medical and aesthetic filling.
[0026] Furthermore, the concentration of L-polylactic acid in the oil phase in step (1) is 2.5-6.6 wt %.
[0027] Furthermore, the organic solvent in step (1) includes any one of dichloromethane, chloroform, ethyl acetate, and ethyl lactate.
[0028] Furthermore, the concentration of sodium carboxymethyl cellulose in the internal aqueous phase in step (2) is 0.1-0.9 wt %.
[0029] Furthermore, in step (3), the concentration of polyvinyl alcohol in the external aqueous phase is 1-1.5 wt %.
[0030] Furthermore, the high-speed emulsification shearing adopts a rotation speed of 6000 rpm and a processing time of 3-5 minutes.
[0031] Furthermore, the rotation speed of the high-speed emulsification shear dispersion in step (4) is 1800-4000 rpm, and the processing time is 10-15 min.
[0032] Furthermore, the stirring conditions in step (5) are: rotation speed 150-180 rpm, and stirring time 12 h.
[0033] Furthermore, the decompression condition in step (5) is: treatment at -0.04 MPa for 0.5 h.
[0034] Furthermore, the freeze-drying conditions in step (5) are: freeze-drying temperature is -60°C, and freeze-drying time is 36-72h.
[0035] The second object of the present invention is to provide an injectable porous microsphere scaffold prepared by any of the methods described above.
[0036] The third object of the present invention is to provide an application of the injectable porous microsphere scaffold, which is to inject the porous microsphere scaffold into the body as a tissue engineering repair material.
[0037] The beneficial effects of the present invention are as follows:
[0038] (1) The present invention provides a method for preparing an injectable porous microsphere scaffold, wherein the obtained microspheres have the characteristics of good uniformity and high stability; in particular, the porous microsphere scaffold has a high porosity and a narrow pore size distribution. The porous microspheres have a large specific surface area and are a more excellent carrier that can be used for cell proliferation and drug controlled release;
[0039] (2) The present invention uses sodium carboxymethyl cellulose as a porogen, which can replace the role of gelatin and can also play a good role in stabilizing the solution system;
[0040] (3) The preparation method provided by the present invention is simple and stable, which can well make up for the deficiency of limited production capacity of microfluidic technology and facilitate industrial production. At the same time, it also provides a simple and easy method for efficiently preparing microspheres with uniform and controllable morphology and high stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 The scanning electron microscope images are of the porous microspheres (samples 1 to 4) prepared in Examples 1 to 4 of the present invention. DETAILED DESCRIPTION
[0042] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is described in detail below in conjunction with the embodiments. It is necessary to point out that the following embodiments are only used to explain and illustrate the present invention and are not used to limit the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above invention content still belong to the protection scope of the present invention.
[0043] Example 1
[0044] A method for preparing an injectable porous microsphere scaffold comprises the following steps:
[0045] (1) dissolving L-polylactic acid in an organic solvent (dichloromethane) to obtain an oil phase, wherein the concentration of L-polylactic acid in the oil phase is 2.5 wt %;
[0046] (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase, wherein the concentration of sodium carboxymethyl cellulose in the inner aqueous phase is 0.1 wt %;
[0047] (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification shearing (6000 rpm, 3 min);
[0048] (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, wherein the concentration of polyvinyl alcohol in the external aqueous phase is 1 wt %, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing (1800 rpm, 10 min) to obtain a W / O / W composite emulsion;
[0049] (5) stirring (rotation speed 150 rpm, stirring time 12 h) under reduced pressure conditions (-0.04 MPa, 0.5 h) to remove the organic solvent and obtain solidified composite microspheres; collecting the microspheres, washing them, and freeze-drying them (-60° C., 36 h) to obtain the injectable porous microsphere scaffold.
[0050] Example 2
[0051] A method for preparing an injectable porous microsphere scaffold comprises the following steps:
[0052] (1) dissolving L-polylactic acid in an organic solvent (dichloromethane) to obtain an oil phase, wherein the concentration of L-polylactic acid in the oil phase is 6.6 wt %;
[0053] (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase, wherein the concentration of sodium carboxymethyl cellulose in the inner aqueous phase is 0.9 wt %;
[0054] (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification shearing (6000 rpm, 5 min);
[0055] (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, wherein the concentration of polyvinyl alcohol in the external aqueous phase is 1.5 wt %, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing (4000 rpm, 15 min) to obtain a W / O / W composite emulsion;
[0056] (5) stirring (rotation speed 180 rpm, stirring time 12 h) under reduced pressure conditions (-0.04 MPa, 0.5 h) to remove the organic solvent and obtain solidified composite microspheres; collecting the microspheres, washing, and freeze-drying (-60° C., 72 h) to obtain the injectable porous microsphere scaffold.
[0057] Example 3
[0058] A method for preparing an injectable porous microsphere scaffold comprises the following steps:
[0059] (1) dissolving L-polylactic acid in an organic solvent (dichloromethane) to obtain an oil phase, wherein the concentration of L-polylactic acid in the oil phase is 5.1 wt %;
[0060] (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase, wherein the concentration of sodium carboxymethyl cellulose in the inner aqueous phase is 0.6 wt %;
[0061] (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification shearing (6000 rpm, 4 min);
[0062] (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, wherein the concentration of polyvinyl alcohol in the external aqueous phase is 1.2 wt %, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing (3000 rpm, 12 min) to obtain a W / O / W composite emulsion;
[0063] (5) stirring (rotation speed 160 rpm, stirring time 12 h) under reduced pressure conditions (-0.04 MPa, 0.5 h) to remove the organic solvent and obtain solidified composite microspheres; collecting the microspheres, washing them, and freeze-drying them (-60° C., 48 h) to obtain the injectable porous microsphere scaffold.
[0064] Example 4
[0065] A method for preparing an injectable porous microsphere scaffold comprises the following steps:
[0066] (1) dissolving L-polylactic acid in an organic solvent (dichloromethane) to obtain an oil phase, wherein the concentration of L-polylactic acid in the oil phase is 3.8 wt %;
[0067] (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase, wherein the concentration of sodium carboxymethyl cellulose in the inner aqueous phase is 0.8 wt %;
[0068] (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification shearing (6000 rpm, 5 min);
[0069] (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, wherein the concentration of polyvinyl alcohol in the external aqueous phase is 1.4 wt %, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing (2100 rpm, 11 min) to obtain a W / O / W composite emulsion;
[0070] (5) stirring (rotation speed 170 rpm, stirring time 12 h) under reduced pressure conditions (-0.04 MPa, 0.5 h) to remove the organic solvent and obtain solidified composite microspheres; collecting the microspheres, washing, and freeze-drying (-60° C., 56 h) to obtain the injectable porous microsphere scaffold.
[0071] Experimental Example 1
[0072] The performance of the porous microsphere scaffolds prepared in Examples 1-4 of the present invention was tested. The samples prepared in Examples 1-4 were respectively recorded as Sample 1, Sample 2, Sample 3, and Sample 4.
[0073] 1. Scanning electron microscope observation
[0074] Scanning electron microscope observation was carried out using FEI-Scios2 Hivac scanning electron microscope. Figure 1 .from Figure 1 It can be seen that the porous microspheres prepared by the method of the present invention have high porosity, spherical appearance and uniform particle size.
[0075] 2. Push force test
[0076] Remove the outer packaging of the product, install the core rod and injection needle in the packaging, remove a small amount of air from the front end of the syringe, then install it on the testing equipment and set the test parameters of the universal material testing machine. The test conditions are as follows:
[0077] a) Test temperature: room temperature.
[0078] b) Test distance: Set the test distance to full scale, 20.000mm.
[0079] c) Pushing speed: Set the pushing speed to 100mm / min
[0080] Test the pushing force according to the prescribed method, and record the maximum pushing force, minimum pushing force and average pushing force values in the platform area of the pushing force curve. The results are shown in Table 1:
[0081] Table 1
[0082] batch number Maximum pushing force (N) Minimum pushing force (N) Average pushing force (N) Sample 1 2.295±0.086 1.790±0.068 2.214±0.088 Sample 2 1.662±0.004 1.175±0.123 1.500±0.005 Sample 3 1.930±0.029 1.489±0.252 1.500±0.005 Sample 4 2.122±0.210 1.103±0.044 1.746±0.054
[0083] It can be seen from Table 1 above that this product has good injection performance.
[0084] 3. Porosity test
[0085] Weigh the pycnometer filled with ethanol as W1, and the mass W S The microspheres are immersed in ethanol, vacuumed and degassed to ensure that the ethanol fills the pores of the porous support, and then filled with ethanol, weighed as W2; after taking out the sample soaked in ethanol, the remaining ethanol and the specific gravity bottle are weighed as W3. The volume of the porous microsphere itself is V S =(W1-W2+W S ) / ρ(ethanol density), the pore volume V of porous microspheres P =(W2-W3-W S ) / ρ, the porosity of PLLA porous microspheres can be obtained by the following formula:
[0086]
[0087] The test results are shown in Table 2:
[0088] Table 2
[0089] batch number Sample 1 Sample 2 Sample 3 Sample 4 Porosity 92.6%±1.6% 92.8%±2.5% 92.4%±1.7% 92.6%±1.6%
[0090] It can be seen from Table 2 that the porous microspheres prepared in the present invention have a relatively high porosity, and the porosities of the porous microspheres prepared in various aspects are not much different, and the process stability is very high.
[0091] 4. Particle size and pore size test
[0092] Relevant tests were carried out with reference to the particle size analysis laser diffraction method of GBT19077-2016, and the results are shown in Table 3.
[0093] Table 3
[0094] batch number Particle size Aperture Sample 1 20-90μm 10-20μm Sample 2 12-50μm 2-8μm Sample 3 15-60μm 3-10μm Sample 4 20-70μm 6-17μm
Claims
1. A method for preparing an injectable porous microsphere scaffold, It is characterized in that The following steps are involved: (1) dissolving L-polylactic acid in an organic solvent to obtain an oil phase; (2) dissolving sodium carboxymethyl cellulose in water to obtain an inner aqueous phase; (3) adding the solution obtained in step (2) to the oil phase obtained in step (1) to form an O / W emulsion by high-speed emulsification and shearing; (4) dissolving polyvinyl alcohol in water to obtain an external aqueous phase, and dispersing the O / W primary emulsion obtained in step (3) into the external aqueous phase by high-speed emulsification shearing to obtain a W / O / W composite emulsion; (5) stirring under reduced pressure to remove the organic solvent to obtain solidified composite microspheres; collecting the microspheres, washing them, and freeze-drying them to obtain the injectable porous microsphere scaffold.
2. The preparation method according to claim 1, It is characterized in that The concentration of L-polylactic acid in the oil phase in step (1) is 2.5-6.6 wt %; preferably, the concentration of sodium carboxymethyl cellulose in the inner aqueous phase in step (2) is 0.1-0.9 wt %.
3. The preparation method according to claim 1, It is characterized in that The organic solvent in step (1) includes any one of dichloromethane, chloroform, ethyl acetate, and ethyl lactate.
4. The preparation method according to claim 1, It is characterized in that The concentration of polyvinyl alcohol in the external aqueous phase in step (3) is 1-1.5 wt %; preferably, the rotation speed of the high-speed emulsification shearing is 6000 rpm, and the processing time is 3-5 min.
5. The preparation method according to claim 1, It is characterized in that The high-speed emulsification shear dispersion in step (4) adopts a rotation speed of 1800-4000 rpm and a processing time of 10-15 min.
6. The preparation method according to claim 1, It is characterized in that The stirring conditions in step (5) are: rotation speed 150-180 rpm, and stirring time 12 h.
7. The preparation method according to claim 1, It is characterized in that The decompression condition in step (5) is: treating at a pressure of -0.04 MPa for 0.5 h.
8. The preparation method according to claim 1, It is characterized in that The freeze-drying conditions in step (5) are: freeze-drying temperature is -60°C, and freeze-drying time is 36-72h.
9. An injectable porous microsphere scaffold prepared by the method according to any one of claims 1 to 8.
10. Use of the injectable porous microsphere scaffold according to claim 9, It is characterized in that The porous microsphere scaffold is injected into the body as a tissue engineering repair material.
Citation Information
Patent Citations
Preparation method for injectable poly(L-lactic acid) microsphere
CN109010910A
High-porosity polycaprolactone porous microsphere scaffold used for bone tissue regeneration and preparation method for high-porosity polycaprolactone porous microsphere scaffold
CN111249524A
Polylactic acid porous microspheres as well as preparation method and application thereof
CN111298196A
Cited By
PLGA-hydroxyapatite composite porous microsphere as well as preparation method and application thereof
CN119656376A
Poly-L-lactic acid porous microspheres, preparation method thereof and injection preparation
CN120919402A
A porous poly-l-lactic acid microsphere and a preparation method thereof, and an injection preparation
CN120919402B
